Lv1
60 积分 2022-12-15 加入
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy
1个月前
已完结
Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis
1个月前
已完结
Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial
1个月前
已完结
Proteome‐Wide Data Guides the Discovery of Lysine‐Targeting Covalent Inhibitors Using DNA‐Encoded Chemical Libraries
2个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
2个月前
已完结
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
2个月前
已完结
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
2个月前
已完结
Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis
2个月前
已完结
Induction of Autoantibodies to Different Interleukin-2 Allotypes
3个月前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
3个月前
已完结
皖公网安备34019202002308
